Загрузка...
Tezacaftor/Ivacaftor in Subjects with Cystic Fibrosis and F508del/F508del-CFTR or F508del/G551D-CFTR
Rationale: Tezacaftor (formerly VX-661) is an investigational small molecule that improves processing and trafficking of the cystic fibrosis transmembrane conductance regulator (CFTR) in vitro, and improves CFTR function alone and in combination with ivacaftor. Objectives: To evaluate the safety and...
Сохранить в:
| Опубликовано в: : | Am J Respir Crit Care Med |
|---|---|
| Главные авторы: | , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Thoracic Society
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5768901/ https://ncbi.nlm.nih.gov/pubmed/28930490 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.201704-0717OC |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|